GlobeNewsWire
21 Sept 2026, 09:47 UTC · 1h ago
Verdict
Headline leans bearish. We score CAPR −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
An FDA advisory committee voted 9-3 that available evidence did not support the efficacy of Deramiocel for treating DMD-associated cardiomyopathy.
Priced inreported by Medscape on July 30, 2026
More negative than 99% of claims this week
FDA briefing documents raised concerns about post-hoc changes to Capricor's statistical analysis plan for the primary endpoint, PUL 2.0, shortly before database unblinding.
Continue reading
5 related stories
More negative than 97% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
So whatAllegations of data manipulation often lead to extended FDA review cycles or demands for entirely new Phase 3 trials.
More negative than 97% of claims this week
Bleichmar Fonti & Auld LLP has filed a securities fraud class action against Capricor Therapeutics alleging misstatements about Deramiocel and clinical data integrity.
Newpress release dated Sept 21, 2026
More negative than 76% of claims this week
Which stocks this story touches
More negative than 97% of ticker scores this week
The company is facing a securities fraud class action lawsuit following a massive stock drop and FDA concerns over clinical data integrity.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
—
CAPR hasn't traded since this ran. Last close $9.06 (Sep 18); the reaction starts at the next open.
CAPR chart →
